Clinical Trial Update: ZN-c3 in Adult Participants With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of ZN-c3 in adults with metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ZN-c3

Snippet

Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: TERMINATED